Granulomatosis with polyangiitis, formerly known as Wegener's granulomatosis or disease, is a systemic, necrotizing small-vessel vasculitis, belonging to the group of anti-neutrophil cytoplasm antibody vasculitis. The therapeutic strategy includes, in most cases, corticosteroids associated, at least in severe forms of the disease, with immunosuppressive agents: cyclophosphamide and rituximab to induce remission, methotrexate, azathioprine and mycophenolate mofetil to prevent relapses. Intravenous immunoglobulins represent an alternative adjuvant therapy.We described 5 cases of patients with granulomatosis with polyangiitis treated with monthly high-dose intravenous immunoglobulins (500. mg/kg/daily for 3 consecutive days for 9. months). No patients experienced adverse reactions, and 4 patients (80%) achieved a complete remission after 9 courses of this therapy, which was maintained also 3. months later, although we are unable to determine whether improvement in outcomes was a direct result of the IVIG. We also discussed the beneficial effects of intravenous immunoglobulins in patients suffering from granulomatosis with polyangiitis, reporting the previously published data.

Guidelli, G.M., Tenti, S., Pascarelli, N.A., Galeazzi, M., Fioravanti, A. (2015). Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature. AUTOIMMUNITY REVIEWS, 14(8), 659-664 [10.1016/j.autrev.2015.03.005].

Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature

GUIDELLI, GIACOMO MARIA;PASCARELLI, NICOLA ANTONIO;GALEAZZI, MAURO;FIORAVANTI, ANTONELLA
2015-01-01

Abstract

Granulomatosis with polyangiitis, formerly known as Wegener's granulomatosis or disease, is a systemic, necrotizing small-vessel vasculitis, belonging to the group of anti-neutrophil cytoplasm antibody vasculitis. The therapeutic strategy includes, in most cases, corticosteroids associated, at least in severe forms of the disease, with immunosuppressive agents: cyclophosphamide and rituximab to induce remission, methotrexate, azathioprine and mycophenolate mofetil to prevent relapses. Intravenous immunoglobulins represent an alternative adjuvant therapy.We described 5 cases of patients with granulomatosis with polyangiitis treated with monthly high-dose intravenous immunoglobulins (500. mg/kg/daily for 3 consecutive days for 9. months). No patients experienced adverse reactions, and 4 patients (80%) achieved a complete remission after 9 courses of this therapy, which was maintained also 3. months later, although we are unable to determine whether improvement in outcomes was a direct result of the IVIG. We also discussed the beneficial effects of intravenous immunoglobulins in patients suffering from granulomatosis with polyangiitis, reporting the previously published data.
2015
Guidelli, G.M., Tenti, S., Pascarelli, N.A., Galeazzi, M., Fioravanti, A. (2015). Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature. AUTOIMMUNITY REVIEWS, 14(8), 659-664 [10.1016/j.autrev.2015.03.005].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/996411
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo